Changes in Prescription Pain Medication and Intra-Articular Corticosteroid Utilization after Intra-Articular Bioengineered Hyaluronic Acid in Routine Clinical Practice
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2021;9(23):11 Changes in Prescription Pain Medication and Intra-Articular Corticosteroid Utilization after Intra-Articular Bio-fermentation Derived Hyaluronic Acid Use in Patients Undergoing Multimodal Pain ManagementWhat this means for my practice?
According to this database study, patients receiving Bio-HA significantly reduced their prescription pain medication and intra-articular corticosteroid utilization. Further high-quality randomized controlled trials are warranted to confirm the results of the current study.
Study Summary
Commercial and Medicare Supplemental claims data was queried and identified patients with 13,999 patients with knee osteoarthritis who had utilized bio-fermentation derived high molecular weight hyaluronic acid (Bio-HA) as a part of multimodal therapy (any combination of corticosteroid injection, opioids and non-opioid pain medications). The primary outcome of interest was multimodal therapy utilization before and after Bio-HA injections. The number of opioid prescriptions filled decreased significantly after Bio-HA injections. Of patients who continued to fill opioid prescriptions, the number of prescriptions per month decreased significantly. Similarly, the number of 'opioid days' supplied decreased after Bio-HA injections and the number of prescription pain medication-free days increased. Patients underwent intra-articular corticosteroid injections following Bio-HA injections.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!